Author

P. M. Dillon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Chakravarti· 1 shared A. Mathew· 1 shared A. Mills· 1 shared A. R. Harris· 1 shared A. R. Post· 1 shared A. S. Silva· 1 shared B. B. Morris· 1 shared C. B. Matsen· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chakravarti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Replicative Instability Drives Cancer Progression

B. B. Morris, J. P. Smith, Q. Zhang, Z. Jiang, O. A. Hampton, M. L. Churchman, S. M. Arnold, D. H. Owen, J. E. Gray, P. M. Dillon, H. H. Soliman, D. G. Stover, H. Colman, A. Chakravarti, K. H. Shain, , M. W. Mayo

This study identifies a pan-cancer class of tumors driven by replicative instability, showing it accelerates cancer progression through genomic changes and transcriptional rewiring.

bioRxiv · May 6, 2022Cancer Biology

Platinum chemotherapy induces lymphangiogenesis in cancerous and healthy tissues that can be prevented with adjuvant anti-VEGFR3 therapy

A. R. Harris, S. Esparza, M. S. Azimi, R. Cornelison, F. N. Azar, D. C. Llaneza, M. Belanger, A. Mathew, S. Tkachenko, M. J. Perez, C. Buchta Rosean, R. Bostic, R. C. Cornelison, K. M. Tate, S. M. Peirce-Cottler, , J. Munson

bioRxiv · Oct 8, 2021Cancer Biology